Exploring systemic inflammation in children with chronic kidney disease: correlates of interleukin 6.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
May 2024
Historique:
received: 23 05 2023
accepted: 13 11 2023
revised: 10 11 2023
medline: 18 3 2024
pubmed: 16 12 2023
entrez: 16 12 2023
Statut: ppublish

Résumé

Systemic inflammation (SI) is linked to chronic kidney disease (CKD) progression and multiple complications. Data regarding SI biomarkers in pediatric patients are scarce. This case-control and cross-sectional study investigates the correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), total iron binding capacity (TIBC) and serum albumin to serum interleukin-6 (IL-6). NLR and PLR were measured in 53 patients (median age: 12.9 years), including 17 on dialysis and 36 with a median glomerular filtration rate of 39 ml/min/1.73m Patients presented higher NLR and PLR and particularly those on dialysis (p < 0.001 and p = 0.001). We observed a significant correlation between natural logarithm (ln) of IL-6 (lnIL-6) and NLR (rs = 0.344, p = 0.014), serum albumin (rs = -0.350, p = 0.011) and TIBC (rs = -0.345, p = 0.012) after adjustment for CKD stage, while the correlation between lnIL-6 and PLR was not significant (rs = 0.206, p = 0.151). Combination of NLR, serum albumin and TIBC predicted high IL-6 (13 patients) with an AUC of 0.771 (95% CI 0.608-0.943). Pairing of NLR ≥ 1.7 and TIBC ≤ 300 μg/dL exhibited the highest sensitivity (76.9%), while incorporating serum albumin ≤ 3.8 g/dL along with them achieved the highest specificity (95%) for detecting high IL-6 levels. Both NLR and PLR levels increase in CKD, especially in patients on chronic dialysis. NLR, rather than PLR, along with TIBC and serum albumin, are associated with IL-6 in pediatric CKD.

Sections du résumé

BACKGROUND BACKGROUND
Systemic inflammation (SI) is linked to chronic kidney disease (CKD) progression and multiple complications. Data regarding SI biomarkers in pediatric patients are scarce. This case-control and cross-sectional study investigates the correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), total iron binding capacity (TIBC) and serum albumin to serum interleukin-6 (IL-6).
METHODS METHODS
NLR and PLR were measured in 53 patients (median age: 12.9 years), including 17 on dialysis and 36 with a median glomerular filtration rate of 39 ml/min/1.73m
RESULTS RESULTS
Patients presented higher NLR and PLR and particularly those on dialysis (p < 0.001 and p = 0.001). We observed a significant correlation between natural logarithm (ln) of IL-6 (lnIL-6) and NLR (rs = 0.344, p = 0.014), serum albumin (rs = -0.350, p = 0.011) and TIBC (rs = -0.345, p = 0.012) after adjustment for CKD stage, while the correlation between lnIL-6 and PLR was not significant (rs = 0.206, p = 0.151). Combination of NLR, serum albumin and TIBC predicted high IL-6 (13 patients) with an AUC of 0.771 (95% CI 0.608-0.943). Pairing of NLR ≥ 1.7 and TIBC ≤ 300 μg/dL exhibited the highest sensitivity (76.9%), while incorporating serum albumin ≤ 3.8 g/dL along with them achieved the highest specificity (95%) for detecting high IL-6 levels.
CONCLUSION CONCLUSIONS
Both NLR and PLR levels increase in CKD, especially in patients on chronic dialysis. NLR, rather than PLR, along with TIBC and serum albumin, are associated with IL-6 in pediatric CKD.

Identifiants

pubmed: 38103065
doi: 10.1007/s00467-023-06234-z
pii: 10.1007/s00467-023-06234-z
doi:

Substances chimiques

Interleukin-6 0
Iron E1UOL152H7
Serum Albumin 0
IL6 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1567-1576

Informations de copyright

© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Références

Akchurin OM, Kaskel F (2015) Update on inflammation in chronic kidney disease. Blood Purif 39:84–92
pubmed: 25662331 doi: 10.1159/000368940
Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711–724
pubmed: 20111974 doi: 10.1007/s00467-009-1427-z
Holle J, Querfeld U, Kirchner M, Anninos A, Okun J, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Duzova A, Anarat A, Shroff R, Bilginer Y, Caliskan S, Candan C, Harambat J, Özcakar ZB, Soylemezoglu O, Tschumi S, Habbig S, Yilmaz E, Balat A, Zurowska A, Cakar N, Kranz B, Ertan P, Melk A, Azukaitis K, Schaefer F (2019) Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease. Pediatr Nephrol 34:2571–2582
pubmed: 31428929 doi: 10.1007/s00467-019-04331-6
Karava V, Kondou A, Dotis J, Christoforidis A, Taparkou A, Farmaki E, Kollios K, Liakopoulos V, Printza N (2023) Association between adipokine profile, systemic inflammation, muscle and protein energy wasting in children with chronic kidney disease. J Ren Nutr 33:629–638
pubmed: 37178774 doi: 10.1053/j.jrn.2023.05.002
Akchurin O, Patino E, Dalal V, Meza K, Bhatia D, Brovender S, Zhu YS, Cunningham-Rundles S, Perelstein E, Kumar J, Rivella S, Choi ME (2019) Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD. Kidney Int Rep 4:470–483
pubmed: 30899874 doi: 10.1016/j.ekir.2018.12.006
Yamamura-Miyazaki N, Michigami T, Ozono K, Yamamoto K, Hasuike Y (2022) Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease. Clin Exp Nephrol 26:1014–1021
pubmed: 35612637 doi: 10.1007/s10157-022-02238-5
Meza K, Biswas S, Zhu YS, Gajjar A, Perelstein E, Kumar J, Akchurin O (2021) Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease. Pediatr Nephrol 36:1579–1587
pubmed: 33387018 doi: 10.1007/s00467-020-04846-3
Lai HL, Kartal J, Mitsnefes M (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-alpha. Pediatr Nephrol 22:1751–1756
pubmed: 17541791 doi: 10.1007/s00467-007-0533-z
Don BR, Kaysen G (2004) Serum albumin: relationship to inflammation and nutrition. Semin Dial 17:432–437
pubmed: 15660573 doi: 10.1111/j.0894-0959.2004.17603.x
Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2009) Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol 29:571–581
pubmed: 19136818 pmcid: 2818472 doi: 10.1159/000191470
Graterol Torres F, Molina M, Soler-Majoral J, Romero-González G, Rodríguez Chitiva N, Troya-Saborido M, SociasRullan G, Burgos E, Paúl Martínez J, UrrutiaJou M, Cañameras C, RieraSadurní J, Vila A, Bover J (2022) Evolving concepts on inflammatory biomarkers and malnutrition in chronic kidney disease. Nutrients 4:4297
doi: 10.3390/nu14204297
Brito GMC, Fontenele AMM, Carneiro ECRL, Nogueira IAL, Cavalcante TB, Vale AAM, Monteiro SCM, Salgado Filho N (2021) Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte ratios in nondialysis chronic kidney patients. Int J Inflam 2021:6678960
pubmed: 34257898 pmcid: 8245254
Okyay GU, Inal S, Oneç K, Er RE, Paşaoğlu O, Paşaoğlu H, Derici U, Erten Y (2013) Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail 35:29–36
pubmed: 23113674 doi: 10.3109/0886022X.2012.734429
Li P, Xia C, Liu P, Peng Z, Huang H, Wu J, He Z (2020) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD). BMC Nephrol 21:511
pubmed: 33238906 pmcid: 7690201 doi: 10.1186/s12882-020-02174-0
Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T, Sevinc M, Akgol C, Kayalar AO, Ucar ZA, Bayraktar F, Unsal A (2016) Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol 85:199–208
pubmed: 26521887 doi: 10.5414/CN108584
Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ (2012) The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail 34:155–159
pubmed: 22172001 doi: 10.3109/0886022X.2011.641514
Valga F, Monzón T, Henriquez F, Antón-Pérez G (2019) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as biological markers of interest in kidney disease. Nefrologia 39:243–249
pubmed: 30782498 doi: 10.1016/j.nefro.2018.11.005
Cetın N, Kocaturk E, Tufan AK, Kıraz ZK, Alatas O (2022) Immature granulocytes as biomarkers of inflammation in children with predialysis chronic kidney disease. Pediatr Nephrol 38:219–225
pubmed: 35445974 doi: 10.1007/s00467-022-05530-4
Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637
pubmed: 19158356 pmcid: 2653687 doi: 10.1681/ASN.2008030287
Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I (2010) Which is the best way for estimating transferrin saturation? Ren Fail 32:1022–1023
pubmed: 20722575 doi: 10.3109/0886022X.2010.502609
Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47:139–148
pubmed: 16377395 doi: 10.1053/j.ajkd.2005.09.014
Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16(Suppl 1):S83–S88
pubmed: 15938042 doi: 10.1681/ASN.2004110972
Zhong X, Ma A, Zhang Z, Liu Y, Liang G (2021) Neutrophil-to-lymphocyte ratio as a predictive marker for severe pediatric sepsis. Transl Pediatr 10:657–665
pubmed: 33880335 pmcid: 8041612 doi: 10.21037/tp-21-47
Eun S, Ho IG, Bae GE, Kim H, Koo CM, Kim MK, Yoon SH (2021) Neutrophil-to-lymphocyte ratio for the diagnosis of pediatric acute appendicitis: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 25:7097–7107
pubmed: 34859875
Han SY, Lee IR, Park SJ, Kim JH, Il SJ (2016) Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection. Korean J Pediatr 59:139–144
pubmed: 27186221 pmcid: 4865625 doi: 10.3345/kjp.2016.59.3.139
Omran A, Awad H, Ibrahim M, El-Sharkawy S, Elfiky S, Rezk AR (2022) Lung ultrasound and neutrophil lymphocyte ratio in early diagnosis and differentiation between viral and bacterial pneumonia in young children. Children (Basel) 9:1457
pubmed: 36291392
Aryani IGAD, Yantie NPVK, Gunawijaya E, Gustawan IW (2021) Correlation between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and mean platelet volume with severity of carditis in children with rheumatic fever. Cardiol Young 32:1396–1400
doi: 10.1017/S1047951121004194
O’Brien CE, Price ET (2013) The blood neutrophil to lymphocyte ratio correlates with clinical status in children with cystic fibrosis: a retrospective study. PLoS One 8:e77420
pubmed: 24098587 pmcid: 3788810 doi: 10.1371/journal.pone.0077420
Milas GP, Fragkos S (2021) Neutrophil to lymphocyte ratio and gastrointestinal involvement among Henoch Schonlein purpura patients: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr 73:437–443
pubmed: 34546994 doi: 10.1097/MPG.0000000000003185
Chang LS, Lin YJ, Yan JH, Guo MMH, Lo MH, Kuo HC (2020) Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease. BMC Pediatr 20:398
pubmed: 32838756 pmcid: 7446151 doi: 10.1186/s12887-020-02285-5
Lano G, Sallée M, Pelletier M, Bataille S, Fraisse M, McKay N, Brunet P, Dou L, Burtey S (2022) Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis. Nephrol Dial Transplant 37:2528–2537
pubmed: 35146525 doi: 10.1093/ndt/gfab350
Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ (2013) Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 17:391–396
pubmed: 23522328 doi: 10.1111/hdi.12040
Moosmann J, Krusemark A, Dittrich S, Ammer T, Rauh M, Woelfle J, Metzler M, Zierk J (2022) Age- and sex-specific pediatric reference intervals for neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio. Int J Lab Hematol 44:296–301
pubmed: 34816610 doi: 10.1111/ijlh.13768
An X, Mao HP, Wei X, Chen JH, Yang X, Li ZB, Yu XQ, Li ZJ (2012) Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients. Int Urol Nephrol 44:1521–1528
pubmed: 22290530 doi: 10.1007/s11255-012-0130-3
Li H, Lu X, Xiong R, Wang S (2017) High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients. Mediators Inflamm 2017:9327136
pubmed: 28316378 pmcid: 5339486 doi: 10.1155/2017/9327136
Abe T, Kato S, Tsuruta Y, Sugiura S, Katsuno T, Kosugi T, Tsuboi N, Matsuo S, Maruyama S (2015) Neutrophil/lymphocyte ratio as a predictor of cardiovascular events in incident dialysis patients: a Japanese prospective cohort study. Clin Exp Nephrol 19:718–724
pubmed: 25348369 doi: 10.1007/s10157-014-1046-2
Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML (2016) Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail 38:70–76
pubmed: 26540580 doi: 10.3109/0886022X.2015.1104990
Soehnlein O (2012) Multiple roles for neutrophils in atherosclerosis. Circ Res 110:875–888
pubmed: 22427325 doi: 10.1161/CIRCRESAHA.111.257535
Hedrick CC (2015) Lymphocytes in atherosclerosis. Arterioscler Thromb Vasc Biol 35:253–257
pubmed: 25609772 pmcid: 4327776 doi: 10.1161/ATVBAHA.114.305144
Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, Wang W, Huang L, Tang W, Sun D, Zhang L, Wang F, Zhao MH, Tao L, He K, Xu H, C-STRIDE study group (2019) Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med 17:86
pubmed: 30876475 pmcid: 6420746 doi: 10.1186/s12967-019-1808-4
Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, Utas C (2013) Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol 26:358–365
pubmed: 22573523 doi: 10.5301/jn.5000152
Altunoren O, Akkus G, Sezal DT, Ciftcioglu M, Guzel FB, Isiktas S, Torun GI, Uyan M, Sokmen MF, Sevim HA, Sarısık FN, Senel ME, Erken E, Gungor O (2019) Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression? Int Urol Nephrol 51:129–137
pubmed: 30276600 doi: 10.1007/s11255-018-1994-7
Fertrin KY (2020) Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick? Hematology Am Soc Hematol Educ Program 2020:478–486
pubmed: 33275757 pmcid: 7727593 doi: 10.1182/hematology.2020000132
Okuda Y, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K (2019) Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy. Pediatr Nephrol 34:1799–1809
pubmed: 31218394 pmcid: 6776669 doi: 10.1007/s00467-019-04270-2
Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S (2008) Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 3:759–767
pubmed: 18287254 pmcid: 2386701 doi: 10.2215/CJN.02720707
Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630–637
pubmed: 11849406 doi: 10.1046/j.1523-1755.2002.00169.x
Oliveira EA, Cheung WW, Toma KG, Mak RH (2019) Muscle wasting in chronic kidney disease. Pediatr Nephrol 33:789–798
doi: 10.1007/s00467-017-3684-6

Auteurs

Vasiliki Karava (V)

Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece. vasilikikarava@hotmail.fr.

Antonia Kondou (A)

Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece.

John Dotis (J)

Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece.

Anna Taparkou (A)

Pediatric Immunology and Rheumatology Referral Center, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Evangelia Farmaki (E)

Pediatric Immunology and Rheumatology Referral Center, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Konstantinos Kollios (K)

3rd Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Nikoleta Printza (N)

Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH